New Clinical studies in China is significantly inreased with double because of improvement of review process and participatin into ICH. Japan keep stable, but an initiative to improve drug development environment in Japan
New clinical study in 2018: 7,606 China is becoming attractive country [ 845 in 2016 -> 1251 in 2017 -> 1969 in 2018]
Japan is flat [ 586 in 2016 -> 588 in 2017 -> 562 in 2018]
